Amgen says cancer treatment missed endpoint in late-stage clinical trial
September 27, 2016 at 08:26 AM EDT
Company shares fell 1.5% in premarket trading Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.